Announcements Trials
Browse Landscape

Phase

Phase 2 41Phase 1/2 25Phase 1 14Phase 3 11Phase NA 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 3Recurrence 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Carcinoma, Hepatocellular 1Amyloidosis 1

Interventions

Cyclophosphamide 17fludarabine phosphate 12Rituximab 12Peripheral Blood Stem Cell Transplantation 12Filgrastim 11Cyclosporine 11Whole-Body Irradiation 8Mycophenolic Acid 8Radiotherapy 7Busulfan 7Antilymphocyte Serum 7Vincristine 6Prednisone 6Melphalan 6Etoposide 6Methotrexate 5Psychiatric Rehabilitation 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4Therapeutics 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3Doxorubicin 3Cytarabine 3Carmustine 3Aprepitant 3Analgesia 3plerixafor 2Vindesine 2Tacrolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Large B-Cell, Diffuse × Lenalidomide × Clear all
NCT04432402 2020-06-16

Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown
124 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡